Detalles de la búsqueda
1.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Eur Urol
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490854
2.
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.
Eur Urol Oncol
; 6(4): 399-405, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754722
3.
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Eur Urol
; 80(4): 405-414, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34247896
4.
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
Int J Radiat Oncol Biol Phys
; 103(5): 1061-1067, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30557672
5.
Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?
Front Oncol
; 7: 108, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620579
6.
Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer.
Cureus
; 9(10): e1769, 2017 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29238628
Resultados
1 -
6
de 6
1
Próxima >
>>